Zeria Pharmaceutical News

Zeria Pharmaceutical: Overview of Q1 2025 earnings report.

Aug 1 03:00 ET

Zeria Pharmaceutical: Announcements of individual stocks: Development and sales contract for functional dyspepsia treatment using acotiamide hydrochloride hydrate in European, USA, and Canada regions.

Jun 19 00:00 ET

Zeria Pharmaceutical: Announcements of individual stocks regarding the absorption merger (simple merger, abbreviated merger) of a wholly-owned subsidiary.

Jun 13 03:00 ET

Zeria Pharmaceutical: Announcements of individual stocks regarding compliance with listing maintenance criteria.

Jun 3 23:00 ET

Zeria Pharmaceutical: [Delayed] Consolidated Earnings for the Fiscal Year Ended 2024/3/31 [Japanese Accounting Standards]

Jun 2 23:00 ET

Zeria Pharmaceutical: 2024 financial results overview

May 9 03:00 ET

Zeria Pharmaceutical: Notice regarding executive personnel affairs

May 9 03:00 ET

Zeria Pharmaceutical: Notice Concerning Organizational Changes and Executive Personnel

Mar 8 02:15 ET

Zeria Pharmaceutical: [Delayed]Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2024[Japanese GAAP]

Feb 15 23:45 ET

Zeria Pharmaceutical: Summary of Financial Results for the third quarter 2024

Feb 1 02:00 ET

Zeria Pharmaceutical: [Delayed]Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2024[Japanese GAAP]

Nov 15, 2023 19:30 ET

Zeria Pharmaceutical: Summary of Financial Results for the second quarter 2024

Nov 1, 2023 03:00 ET

Zeria Pharmaceutical: Notice of new releases of “Prevaline Alpha Quick Ointment” and “Prevaline Alpha Quick Cream”

Nov 1, 2023 03:00 ET

Zeria Pharmaceutical: Notice of changes in the contents of the Shareholder Special Offer Course

Sep 3, 2023 22:00 ET

Zeria Pharmaceutical: [Delayed]Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2024[Japanese GAAP]

Aug 21, 2023 21:00 ET

Zeria Pharmaceutical: Summary of Financial Results for the first quarter 2024

Aug 3, 2023 03:00 ET

Zeria Pharmaceutical: Tillotts Pharma and TVM Capital Life Science announce they will establish Mage Biologics for the purpose of developing oral antibody therapy against ulcerative colitis

Jul 28, 2023 00:00 ET

Zeria Pharmaceutical: Notice regarding the acquisition of approval in Thailand for the functional dyspepsia remedy “Acoside Acetate 100 mg”

Jul 6, 2023 02:00 ET

Zeria Pharmaceutical: Plans for compliance with listing maintenance standards

Jun 29, 2023 03:00 ET

Zeria Pharmaceutical: [Delayed]Consolidated Financial Results for the Fiscal Year Ended March 31, 2023[Japanese GAAP]

Jun 1, 2023 04:00 ET